The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An observational study on the relationship between tyrosine kinase inhibitor treatment-free remission and cytotoxic T-lymphocytes in patients with chronic phase chronic myeloid leukemia.
 
Tatsuro Jo
Honoraria - Abbvie; Amgen; Astellas Pharma; Bristol Myers Squibb Foundation; Chugai Pharma; Eisai; Janssen; Kyowa Kirin; Meiji Seika Kaisha; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Pfizer; PharmaEssentia; Sanofi; SymBio Pharmaceuticals; Takeda
Research Funding - Bristol Myers Squibb Foundation
 
Yoshio Saburi
No Relationships to Disclose
 
Taro Masunari
No Relationships to Disclose
 
Toru Kiguchi
Honoraria - Abbvie; Janssen; Nippon Shinyaku; SymBio Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
 
Nobuo Sezaki
No Relationships to Disclose
 
Eiichi Ohtsuka
No Relationships to Disclose
 
Takahiro Sakai
No Relationships to Disclose
 
Kazuhiro Noguchi
No Relationships to Disclose
 
Ritsuko Koketsu
No Relationships to Disclose